NEW YORK, Nov. 11 (GenomeWeb News) - Agilent Technology's life sciences and chemical analysis unit, which sells the company's genomics and proteomics product lines, had revenue growth of 10 percent for the quarter ending Oct. 31, the company reported today.

"LSCA shows few signs of slowing from its recent double-digit growth trend," the company said in a statement.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.